![Stephen Basso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Basso
Finanzdirektor/CFO bei
INNOVIVA, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Stephen Basso currently serves as Treasurer & Director at La Jolla Pharmaceutical Co., Chief Financial Officer at Innoviva, Inc. since 2023, and Treasurer at Tetraphase Pharmaceuticals, Inc. Formerly, Mr. Basso was Vice President-North America Commercial at Alexion Pharmaceuticals, Inc. from 2016 to 2017, Chief Financial Officer & Senior VP-Finance at Inozyme Pharma, Inc. from 2020 to 2021, and Chief Operating & Financial Officer at Cybrexa, Inc. Education includes an MBA from Boston College and an undergraduate degree from Providence College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INNOVIVA, INC. 0,12 % | 20.05.2026 | 88.571 ( 0,12 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Stephen Basso
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOVIVA, INC. | Finanzdirektor/CFO | 21.08.2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Direktor/Vorstandsmitglied | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Treasurer | - |
Ehemalige bekannte Positionen von Stephen Basso
| Unternehmen | Position | Ende |
|---|---|---|
| INOZYME PHARMA, INC. | Finanzdirektor/CFO | 14.05.2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Finanzdirektor/CFO | - |
Ausbildung von Stephen Basso
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
